immunotherapy of cancer Active8: A randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with motolimod immunotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
Year: 2016
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Institutions: University of California San Diego, Moores Cancer Center, Winship Cancer Institute, University of Southern California, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, The Barbara Ann Karmanos Cancer Institute, The University of Kansas Cancer Center, University of Cincinnati, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, UPMC Hillman Cancer Center
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2587952644